Viewing Study NCT06243887



Ignite Creation Date: 2024-05-06 @ 8:04 PM
Last Modification Date: 2024-10-26 @ 3:20 PM
Study NCT ID: NCT06243887
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-03-22
First Post: 2023-12-19

Brief Title: Implementing Enhanced Recovery After Surgery ERAS Protocol in Patients Undergoing Minimal Invasive Esophagectomy
Sponsor: Assiut University
Organization: Assiut University

Study Overview

Official Title: Implementing Enhanced Recovery After Surgery ERAS Protocol in Patients Undergoing Minimal Invasive Esophagectomy
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Detect impact of enhanced recovery after surgery ERAS on the outcomes of oesophageal surgery
Detailed Description: esophagectomy for both malignant and benign disease has been identified as a particularly complex surgical procedure due to documented high levels of peri-operative morbidity and mortality

A comprehensive review of complications associated with the esophagectomies performed in high-volume esophageal units utilizing a standardized format for documenting complications and quality measures has confirmed an overall complication rate of 59 with 172 of patients sustaining complications of IIIb or greater utilizing the Clavien-Dindo severity grading system post-operative complications include high rate of anastomotic leakage pulmonary infection thoracic duct injury voice changes breathlessness long hospital stay

These outcomes accentuate the need for providing an enhanced recovery after surgery standardized format for esophagectomy which can be routinely applied and audited to improve international outcomes though ERAS lacking randomized control trials

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None